Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 3433 | 2868 | 500 |
| Full Text Views | 10 | 2 | 1 |
| PDF Downloads | 7 | 2 | 0 |
Antimalarial Effects of Clindamycin in Man
David F. Clyde
David F. Clyde
University of Maryland School of Medicine, Baltimore, Maryland 21201
Search for other papers by David F. Clyde in
Current site
Google Scholar
PubMed
Search for other papers by David F. Clyde in
Current site
Google Scholar
PubMed
Robert H. Gilman
Robert H. Gilman
University of Maryland School of Medicine, Baltimore, Maryland 21201
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Vincent C. McCarthy
Vincent C. McCarthy
University of Maryland School of Medicine, Baltimore, Maryland 21201
Search for other papers by Vincent C. McCarthy in
Current site
Google Scholar
PubMed
Search for other papers by Vincent C. McCarthy in
Current site
Google Scholar
PubMed
Clindamycin 450 mg every 8 hours for 3 days cured three non-immune patients of falciparum malaria, although the response was slow. The addition of quinine to this regimen provided an accelerated response and cured 3 of 5 other patients. Single doses of clindamycin given daily for 3 days, with or without quinine, cured 1 of 3 patients. Gastric intolerance to the drugs, probably accentuated by the clinical condition, was pronounced in some cases, the course of treatment being interrupted in three patients for this reason. Chesson strain Plasmodium vivax relapses in man were not inhibited by ingestion of 450 mg of clindamycin every 6 hours for 14 days.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 3433 | 2868 | 500 |
| Full Text Views | 10 | 2 | 1 |
| PDF Downloads | 7 | 2 | 0 |